Overall and cause-specific excess mortality in HIV-positive persons compared with the general population
Belén Alejos, Inmaculada Jarrín(Instituto de Salud Carlos III), Víctor Asensi(Baylor College of Medicine), Juan González‐García(Hospital Universitario La Paz), Ana Gómez‐Berrocal(Hospital Universitario de La Princesa), Jose Iribarren(Apple (Israel)), Víctoria Hernando(Instituto de Salud Carlos III), Jesús Santos(Hospital Clínico Universitario Virgen de la Victoria), Asunción Hernando(Universidad de Alcalá)
Cited by 26
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
|Clinical Microbiology and Infection|2020|128
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples
|American Journal of Epidemiology|2019|116